BACE1 and Alzheimer disease: In studies using the 5XFAD transgenic mouse model, which recapitulates key features of AD, oral administration of phloroglucinol reduced Aβ plaque burden and lowered protein levels of BACE1, a key enzyme in Aβ production (see blue pathway Figure 1) [156,157].